CSI Market
Sign In | Register

Infinity Pharmaceuticals Inc (INFI) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access INFI quarterly Cash Flow →
From Infinity Pharmaceuticals Inc through Dec 31 2018, changes in Dec 31 2022's operating cash flow provide insight into underlying business performance trends.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
12 Months 		(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2018)
Operating Activities
Income-44.37
Depreciation & amortization0.46
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Impairment of Long-Lived Assets Held-for-use0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation3.62
Income (Loss) from Equity Method Investments0.00
Financial Instruments and Foreign Currency Transaction0.00
Marketable Securities Realized Gain Loss-
Amortization Of Loan Commitment Asset-
Impairment Of Investments-
Increase Decrease In Accounts Payable Accrued Expenses And Other Liabilities-0.30
Noncash Interest Expense On Long Term Debt Due To Related Party-
Gain From Written Notice of Termination-
Noncash Royalty Revenue-1.37
Noncash Interest Expense-
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Receivables0.00
Increase (Decrease) in Notes Payable, Current0.00
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.59
Other Working Capital0.00
Other Noncash Income (Expense)0.09
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.03
Discontinued operations0.00
Net Cash flow from Operating Activities-42.43
Investing Activities
Capital Expenditures-0.02
Sale of Capital Items0.00
Proceeds from Maturities, Prepayments and Calls of Available-for-sale Securities16.00
Payments to Acquire Available-for-sale Securities, Debt-16.04
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.06
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.07
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-80.88
Proceeds From Issuance Of Long Term Debt From Related Party-
Proceeds From Issuance Of Common Stock To Related Entities-
Release Of Restricted Cash-
Proceeds From Issuance Of Common Stock To Related Party-
Payments On Construction Liability-
Payments Of Financing Obligation-
Proceeds From Sale Of Future Royalties Net-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents80.88
Proceeds From Sale Of Future Royalties Related Party Net-
Proceeds From Issuance Of Common Stock Under Sales Facility-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.07
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-42.45
Total Cash Flow-42.41
4 historic quarters locked

Sign in to unlock the full Infinity Pharmaceuticals Inc cash flow history.

Sign In Create Free Account

About Infinity Pharmaceuticals Inc Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001113148-23-000009

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License